Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

A patient with complete hair loss regrew all her hair using tofacitinib.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Gefitinib can cause hair loss without scarring.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Upadacitinib improved multiple immune-related conditions in one patient.